Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China
· Delayed Price · Currency is CNY 24.34
-0.34 (-1.38%)
At close: Mar 9, 2026
SHE:003020 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,629 | 3,456 | 4,495 | 3,956 | 4,248 | 3,185 | Upgrade
|
| Market Cap Growth | 31.82% | -23.11% | 13.63% | -6.89% | 33.39% | - | Upgrade
|
| Enterprise Value | 4,358 | 3,230 | 4,180 | 3,310 | 3,631 | 2,938 | Upgrade
|
| Last Close Price | 24.34 | 17.50 | 22.33 | 19.51 | 20.95 | 15.55 | Upgrade
|
| PE Ratio | 28.64 | 21.52 | 19.83 | 18.90 | 24.67 | 23.57 | Upgrade
|
| Forward PE | - | 15.83 | 17.14 | - | - | - | Upgrade
|
| PS Ratio | 3.14 | 2.28 | 2.37 | 1.53 | 1.87 | 1.68 | Upgrade
|
| PB Ratio | 2.38 | 1.81 | 2.40 | 2.67 | 3.26 | 2.71 | Upgrade
|
| P/TBV Ratio | 2.85 | 2.22 | 3.00 | 2.83 | 3.50 | 2.79 | Upgrade
|
| P/FCF Ratio | 38.13 | 80.29 | 732.38 | - | - | 27.39 | Upgrade
|
| P/OCF Ratio | 17.88 | 17.50 | 22.07 | 19.72 | 26.77 | 18.47 | Upgrade
|
| EV/Sales Ratio | 2.96 | 2.13 | 2.20 | 1.28 | 1.60 | 1.55 | Upgrade
|
| EV/EBITDA Ratio | 18.23 | 14.24 | 17.31 | 14.99 | 18.17 | 18.42 | Upgrade
|
| EV/EBIT Ratio | 34.44 | 21.26 | 20.31 | 16.99 | 21.07 | 20.46 | Upgrade
|
| EV/FCF Ratio | 35.90 | 75.04 | 681.13 | - | - | 25.26 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.06 | 0.05 | 0.01 | 0.02 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.28 | 0.50 | 0.35 | 0.06 | 0.12 | - | Upgrade
|
| Debt / FCF Ratio | 0.55 | 2.76 | 14.41 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.21 | -0.20 | -0.25 | -0.42 | -0.48 | -0.65 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.81 | -1.72 | -1.97 | -2.85 | -3.15 | -4.81 | Upgrade
|
| Net Debt / FCF Ratio | -3.43 | -9.05 | -77.56 | 13.74 | 22.30 | -6.59 | Upgrade
|
| Asset Turnover | 0.57 | 0.60 | 0.83 | 1.36 | 1.42 | 1.56 | Upgrade
|
| Inventory Turnover | 2.18 | 2.07 | 3.08 | 5.88 | 7.16 | 6.77 | Upgrade
|
| Quick Ratio | 1.64 | 1.60 | 1.62 | 1.61 | 2.98 | 3.08 | Upgrade
|
| Current Ratio | 2.21 | 2.04 | 2.12 | 2.33 | 3.72 | 3.77 | Upgrade
|
| Return on Equity (ROE) | 8.27% | 8.05% | 13.95% | 15.03% | 13.90% | 15.32% | Upgrade
|
| Return on Assets (ROA) | 3.07% | 3.75% | 5.59% | 6.41% | 6.71% | 7.40% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.28% | 9.23% | 16.64% | 22.29% | 27.55% | 30.97% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 7.60% | 10.60% | 13.00% | 12.80% | 12.00% | Upgrade
|
| Earnings Yield | 3.51% | 4.65% | 5.04% | 5.29% | 4.05% | 4.24% | Upgrade
|
| FCF Yield | 2.62% | 1.25% | 0.14% | -1.16% | -0.66% | 3.65% | Upgrade
|
| Dividend Yield | 2.03% | 2.86% | 1.87% | 1.64% | 1.65% | 1.59% | Upgrade
|
| Payout Ratio | 67.87% | 50.40% | 27.03% | 30.99% | 26.90% | 20.78% | Upgrade
|
| Buyback Yield / Dilution | 0.64% | 0.47% | -1.75% | -0.49% | -33.01% | -0.03% | Upgrade
|
| Total Shareholder Return | 2.66% | 3.33% | 0.12% | 1.15% | -31.37% | 1.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.